Chronic Myelomonocytic Leukemia Completed Phase 1 Trials for Carboxymethylcellulose (DB11059)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

IndicationStatusPhase
DBCOND0028572 (Chronic Myelomonocytic Leukemia)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01834248DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaTreatment